(function(){var loadHandler=window['sl_{D0ADD9BC-5BCE-4B01-85F9-188A7AEC90E6}'];loadHandler&&loadHandler(143, '<div id="spr0_aef747d"><div id="spr1_aef747d" class="kern slide"><img id="img0_aef747d" src="data/img2.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_aef747d" class="kern slide"><div id="spr3_aef747d" style="left:25.636px;top:59.397px;"><div style="width:0px;"><span id="txt0_aef747d" data-width="648.791016" style="left:7.2px;top:1.323px;">A 67-year-old woman was referred to the breast cancer clinic by GP because of a lump in</span></div><div style="width:0px;"><span id="txt1_aef747d" data-width="623.232422" style="left:7.2px;top:22.923px;">upper-outer quadrant in the left breast.  Mammography shows tumour of ~ 3.5 cm in</span></div><div style="width:0px;"><span id="txt2_aef747d" data-width="632.583984" style="left:7.2px;top:44.523px;">diameter.  Core-biopsy confirmed invasive ductal carcinoma.  The axillary lymph nodes</span></div><div style="width:0px;"><span id="txt3_aef747d" data-width="593.666016" style="left:7.2px;top:66.123px;">are enlarged but not fixed.  No evidence of deposits in liver (liver function tests &amp;</span></div><div style="width:0px;"><span id="txt4_aef747d" data-width="645.503906" style="left:7.2px;top:87.723px;">ultrasound are normal), lungs (chest x-ray), bones (scintigraphy) or brain (CT). Molecular</span></div><div style="width:0px;"><span id="txt5_aef747d" data-width="645.583008" style="left:7.2px;top:109.323px;">markers: Estrogen receptor positive, Progesterone receptor positive, HER2 negative.  No</span></div><div style="width:0px;"><span id="txt6_aef747d" data-width="653.229492" style="left:7.2px;top:130.923px;">familial history of breast cancer.  History of DVT.  Bone scan shows reduced bone density.</span></div><div style="width:0px;"><span id="txt7_aef747d" data-width="246.682617" style="left:7.2px;top:152.523px;">No other concomitant conditions.</span></div><div style="width:0px;"><span id="txt8_aef747d" data-width="625.086914" style="left:7.2px;top:195.723px;">Present case summary to the class.  Compare the treatments below; suggest which of</span></div><div style="width:0px;"><span id="txt9_aef747d" data-width="329.273438" style="left:7.2px;top:217.323px;">them may be suitable and which is not, why?</span></div><div style="width:0px;"><span id="txt10_aef747d" data-width="646.989258" style="left:7.2px;top:260.523px;">1. Mastectomy followed by a course of adjuvant cytotoxic chemotherapy; Then adjuvant</span></div><div style="width:0px;"><span id="txt11_aef747d" data-width="160.532227" style="left:7.2px;top:282.123px;">tamoxifen for 5 years.</span></div><div style="width:0px;"><span id="txt12_aef747d" data-width="646.989258" style="left:7.2px;top:315.723px;">2. Mastectomy followed by a course of adjuvant cytotoxic chemotherapy; Then adjuvant</span></div><div style="width:0px;"><span id="txt13_aef747d" data-width="150.750000" style="left:7.2px;top:337.323px;">letrozole for 5 years.</span></div><div style="width:0px;"><span id="txt14_aef747d" data-width="647.059570" style="left:7.2px;top:370.923px;">3. Neo-adjuvant cytotoxic chemotherapy for 3 months followed by conservative surgery.</span></div><div style="width:0px;"><span id="txt15_aef747d" data-width="651.541992" style="left:7.2px;top:392.523px;">After surgery: adjuvant cytotoxic chemotherapy, local radiotherapy &amp; 5 years of adjuvant</span></div><div style="width:0px;"><span id="txt16_aef747d" data-width="86.941406" style="left:7.2px;top:414.123px;">Fulvestrant.</span></div><div style="width:0px;"><span id="txt17_aef747d" data-width="482.422852" style="left:7.2px;top:447.723px;">Suggest what might be missed in the assessment and treatments?</span></div></div><div id="spr4_aef747d" style="top:3.436px;"><div style="width:0px;"><span id="txt18_aef747d" data-width="91.617188" style="left:201.641px;top:-0.954px;">Task 3</span></div></div></div></div>');})();